Lacosamide 69315-0318-46
- Manufacturer
- Leading Pharma, Llc
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- February 6, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216461
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
69315-0318-46Selected465 mL in 1 BOTTLE, PLASTIC (69315-318-46)
Other packages for this product(1)
200 mL in 1 BOTTLE, PLASTIC (69315-318-20)